|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/04 | (2006.01) |
| A61K 31/336 | (2006.01) | ||
| A61K 31/396 | (2006.01) |
| (11) | Number of the document | 1819353 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05853385.2 |
| Date of filing the European patent application | 2005-12-07 | |
| (97) | Date of publication of the European application | 2007-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2011-02-23 |
| (46) | Date of publication of the claims translation | 2011-06-27 |
| (86) | Number | PCT/US2005/044451 |
| Date | 2005-12-07 |
| (87) | Number | WO 2006/063154 |
| Date | 2006-06-15 |
| (30) | Number | Date | Country code |
| 634366 P | 2004-12-07 | US | |
| 655930 P | 2005-02-23 | US |
| (72) |
LEWIS, Evan R., US
HO, Mark Nguyen, US
FONSECA, Fabiana N., US
|
| (73) |
Onyx Therapeutics, Inc.,
249 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicija, skirta proteasomos slopinimui |
| COMPOSITION FOR PROTEASOME INHIBITION |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 347.00 EUR |